Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups.

    Du C, Zhou Y, Cai H, Zhao G, Fu H, Shi YQ.

    J Surg Oncol. 2012 Mar;105(3):323-8. doi: 10.1002/jso.22082. Epub 2011 Aug 24.

    PMID:
    22271501
    [PubMed - indexed for MEDLINE]
    2.

    Kallikrein-related peptidases (KLKs) as novel potential biomarkers in gastric cancer: an open yet challenging road lies ahead.

    Scorilas A, Mavridis K.

    J Surg Oncol. 2012 Mar;105(3):223-4. doi: 10.1002/jso.22041. Epub 2011 Aug 8. No abstract available.

    PMID:
    22271498
    [PubMed - indexed for MEDLINE]
    3.

    Participation and conflict in the decision-making process for endoscopic resection or surgical gastrectomy for early gastric cancer.

    Lee H, Lee YC, Shin S, Park JC, Shin SK, Lee SK, Noh SH.

    J Surg Oncol. 2012 Jan 18. doi: 10.1002/jso.23049. [Epub ahead of print]

    PMID:
    22258736
    [PubMed - as supplied by publisher]
    4.

    Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.

    Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB, Zan WH.

    J Surg Oncol. 2012 Jan 9. doi: 10.1002/jso.23008. [Epub ahead of print]

    PMID:
    22231933
    [PubMed - as supplied by publisher]
    5.

    Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma.

    Lin XD, Chen SQ, Qi YL, Zhu JW, Tang Y, Lin JY.

    J Surg Oncol. 2012 Jan 9. doi: 10.1002/jso.23037. [Epub ahead of print]

    PMID:
    22231149
    [PubMed - as supplied by publisher]
    6.

    Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer.

    Wu Y, Yamada S, Izumi H, Li Z, Shimajiri S, Wang KY, Liu YP, Kohno K, Sasaguri Y.

    J Surg Oncol. 2012 Jun 1;105(7):724-30. doi: 10.1002/jso.23030. Epub 2012 Jan 3.

    PMID:
    22215526
    [PubMed - in process]
    7.

    Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.

    Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J.

    J Surg Oncol. 2012 Jan;105(1):31-7. doi: 10.1002/jso.22025. Epub 2011 Aug 30.

    PMID:
    22161898
    [PubMed - indexed for MEDLINE]
    8.

    Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection.

    Imano M, Imamoto H, Itoh T, Satou T, Peng YF, Yasuda A, Kato H, Shiraishi O, Shinkai M, Yasuda T, Takeyama Y, Okuno K, Shiozaki H.

    J Surg Oncol. 2012 Jan;105(1):43-7. doi: 10.1002/jso.22065. Epub 2011 Aug 11.

    PMID:
    21837682
    [PubMed - indexed for MEDLINE]
    9.

    Prognostic significance of lymph node station 7 for patients with gastric cancers underwent radical surgery.

    Tong JH, Sun Z, Zhu Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Xu HM.

    J Surg Oncol. 2012 Jun 15;105(8):805-12. doi: 10.1002/jso.23011. Epub 2011 Dec 27.

    PMID:
    22212911
    [PubMed - in process]
    10.

    The decision criterion of histological mixed type in "T1/T2" gastric carcinoma-comparison between TNM classification and Japanese classification of gastric cancer.

    Shimizu H, Ichikawa D, Komatsu S, Okamoto K, Shiozaki A, Fujiwara H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Kishimoto M, Yanagisawa A, Otsuji E.

    J Surg Oncol. 2012 Jun 15;105(8):800-4. doi: 10.1002/jso.23010. Epub 2011 Dec 20.

    PMID:
    22189799
    [PubMed - in process]
    11.

    Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer.

    Li ZY, Koh CE, Bu ZD, Wu AW, Zhang LH, Wu XJ, Wu Q, Zong XL, Ren H, Tang L, Zhang XP, Li JY, Hu Y, Shen L, Ji JF.

    J Surg Oncol. 2012 Jun 15;105(8):793-9. doi: 10.1002/jso.23009. Epub 2011 Dec 20.

    PMID:
    22189752
    [PubMed - in process]
    12.

    The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.

    Kim HI, Kim H, Cho HW, Kim SY, Song KJ, Hyung WJ, Park CG, Kim CB.

    J Surg Oncol. 2011 Dec;104(7):728-33. doi: 10.1002/jso.22038. Epub 2011 Jul 25.

    PMID:
    21792941
    [PubMed - indexed for MEDLINE]
    13.

    Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.

    Zhu GL, Sun Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Zhu Z, Xu HM.

    J Surg Oncol. 2012 Jun 15;105(8):786-92. doi: 10.1002/jso.22149. Epub 2011 Nov 21.

    PMID:
    22105768
    [PubMed - in process]
    14.

    Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas.

    Chen YB, Hou JH, Feng XY, Chen S, Zhou ZW, Zhang XS, Cai MY.

    J Surg Oncol. 2012 May;105(6):542-7. doi: 10.1002/jso.22151. Epub 2011 Nov 17.

    PMID:
    22095667
    [PubMed - in process]
    15.

    Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer.

    Chen Y, Pan K, Li S, Xia J, Wang W, Chen J, Zhao J, Lü L, Wang D, Pan Q, Wang Q, Li Y, He J, Li Q.

    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22150. [Epub ahead of print]

    PMID:
    22095633
    [PubMed - as supplied by publisher]
    16.

    Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer.

    Okugawa Y, Toiyama Y, Tanaka K, Matsusita K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K, Kusunoki M.

    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22142. [Epub ahead of print]

    PMID:
    22095522
    [PubMed - as supplied by publisher]
    17.

    The quality of life trajectory of resected gastric cancer.

    Munene G, Francis W, Garland SN, Pelletier G, Mack LA, Bathe OF.

    J Surg Oncol. 2012 Mar 15;105(4):337-41. doi: 10.1002/jso.22139. Epub 2011 Nov 17.

    PMID:
    22095440
    [PubMed - indexed for MEDLINE]
    18.

    Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.

    Woo Y, Hyung WJ, Obama K, Kim HI, Pak KH, Son T, Noh SH.

    J Surg Oncol. 2012 Mar 15;105(4):405-9. doi: 10.1002/jso.22129. Epub 2011 Oct 24.

    PMID:
    22025360
    [PubMed - indexed for MEDLINE]
    19.

    Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.

    Oyama K, Fushida S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Nakagawara H, Tajima H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Tani T, Fujimura T, Ohta T.

    J Surg Oncol. 2012 May;105(6):535-41. doi: 10.1002/jso.22125. Epub 2011 Oct 17.

    PMID:
    22006649
    [PubMed - in process]
    20.

    Pretreatment risk factors for multiple gastric cancer and missed lesions.

    Eom BW, Lee JH, Choi IJ, Kook MC, Nam BH, Ryu KW, Kim YW.

    J Surg Oncol. 2012 Jun 15;105(8):813-7. doi: 10.1002/jso.22124. Epub 2011 Oct 17.

    PMID:
    22006627
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk